Anti-inflammatory therapy reduces wheezing after bronchiolitis

T. Reijonen, M. Korppi, L. Kuikka and K. Remes
Department of Pediatrics, Kuopio (Finland) University Hospital.

OBJECTIVE: To evaluate whether early anti-inflammatory therapy with nebulized cromolyn sodium or budesonide reduces wheezing after bronchiolitis. DESIGN AND SETTING: A randomized, controlled study in a university hospital that provides primary hospital care for all pediatric patients in a defined area. PATIENTS: One hundred consecutive infants younger than 24 months treated in the hospital for acute bronchiolitis. INTERVENTIONS: Thirty-four patients received cromolyn sodium, 20 mg four times a day for 8 weeks and 20 mg three times a day for 8 weeks, and 34 patients received budesonide, 500 micrograms twice a day for 8 weeks and 250 micrograms twice a day for 8 weeks, by a foot pump with a face mask; 32 patients in the control group received no therapy. MAIN OUTCOME MEASURES: Numbers of physician-diagnosed wheezing episodes, hospital admissions for bronchial obstructions, and symptomatic days recorded by the parents. RESULTS: Children in the cromolyn sodium (19%) and budesonide (16%) groups had significantly fewer physician-diagnosed wheezing episodes than those in the control group (47%) during the second 8-week period (P < .05). A significant reduction in hospital admissions for bronchial obstructions was seen in the budesonide group and in the children with atopy in both treatment groups (P < .05). The children with atopy had significantly more subsequent wheezing episodes and hospital admissions than those without atopy (P < .05). The numbers of symptomatic days did not differ significantly among the three groups. CONCLUSIONS: Early anti-inflammatory therapy with nebulized cromolyn sodium or budesonide reduces the number of wheezing episodes and hospital admissions after bronchiolitis. Children with atopy are at high risk of subsequent wheezing episodes, and they particularly benefit from anti-inflammatory therapy.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inhaled corticosteroids and children.
Kohler et al.
NEJM 2006;355:624-624.
FULL TEXT  

Effect of inhaled steroids on lung function in young children: a cohort study
Devulapalli et al.
Eur Respir J 2004;23:869-875.
ABSTRACT | FULL TEXT  

Pharmacologic Treatment of Bronchiolitis in Infants and Children: A Systematic Review
King et al.
Arch Pediatr Adolesc Med 2004;158:127-137.
ABSTRACT | FULL TEXT  

Allergen-Specific Immunoglobulin E Antibodies in Wheezing Infants: The Risk for Asthma in Later Childhood
Kotaniemi-Syrjanen et al.
Pediatrics 2003;111:e255-261.
ABSTRACT | FULL TEXT  

Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases
Wennergren and Kristjansson
Eur Respir J 2001;18:1044-1058.
ABSTRACT | FULL TEXT  

Treatment and Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Infection . Long-Term Effects on Respiratory Outcomes
SIMOES
Am. J. Respir. Crit. Care Med. 2001;163:S14-17.
FULL TEXT  

Predictors of Asthma Three Years After Hospital Admission for Wheezing in Infancy
Reijonen et al.
Pediatrics 2000;106:1406-1412.
ABSTRACT | FULL TEXT  

Prednisolone Plus Albuterol Versus Albuterol Alone in Mild to Moderate Bronchiolitis
Goebel et al.
CLIN PEDIATR 2000;39:213-220.
ABSTRACT  

Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis
Cade et al.
Arch. Dis. Child. 2000;82:126-130.
ABSTRACT | FULL TEXT  

Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing
Fox et al.
Arch. Dis. Child. 1999;80:343-347.
ABSTRACT | FULL TEXT  

ANTI-INFLAMMATORIES REDUCE WHEEZING AFTER BRONCHIOLITIS
JWatch General 1996;1996:3-3.
FULL TEXT